Russia is testing a new method of treating autoimmune diseases
Russian antibodies are completing the first phase of clinical trials for the treatment of autoimmune diseases by the method of monocolonal testing.
“The drug is promising for the treatment of 90% of patients who suffer from ankylosing spondylitis, which can be rendered to 500 thousand – a million of our citizens,” said Deputy Prime Minister Tatyana Golikova at a meeting on the development of genetic technologies.
The meeting is being held in videoconference mode, it is broadcasted by the TV channel “Russia 24”…
All major news are available on the media platform. “Watching”…
Golikova spoke about another development – a genetic kit for the analysis of hereditary mutations in genes, which will allow to determine the hereditary predisposition to cancer and predict the sensitivity of the tumor to certain chemotherapy drugs.
We expect that with the help of improved results of treatment of patients with breast, ovarian, pancreatic cancer. “, – said the Deputy Prime Minister.
The set was created by the Center for Genetic Technologies in Medicine, created on the basis of the Engelhardt Institute for Genetic Biology.
Tatyana Golikova said that the program for genetic research will be extended until 2030.